Your session is about to expire
← Back to Search
Device
Trans-Perineal Grid Technique for Prostate Biopsy
N/A
Waitlist Available
Led By David Woodrum, MD, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Scheduled for a MR guided biopsy or ablation.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
Study Summary
This trial aims to test a new tech to help doctors find the best needle path for prostate treatment.
Who is the study for?
This trial is for individuals scheduled for an MR-guided prostate biopsy or ablation, who have 1-3 suspicious tumor regions on MRI and can consent to the study. They must tolerate anesthesia/sedation. Those with conditions not compatible with MRI or a history of non-skin cancer in the last three years cannot participate.Check my eligibility
What is being tested?
The study is testing a new needle guide grid called Clear Guide SCENERGY - MR, which has VisiMARKER II to help automatically register and target the prostate during biopsies or ablations, aiming to improve needle placement accuracy.See study design
What are the potential side effects?
Potential side effects are not explicitly listed but may include discomfort, bruising, bleeding at the needle insertion site, infection risk from biopsy procedure, and possible allergic reactions to materials used.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for a biopsy or ablation guided by MRI.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Needle placement accuracy
Trial Design
1Treatment groups
Experimental Treatment
Group I: Trans-Perineal Grid for prostate interventionsExperimental Treatment1 Intervention
Subjects will have the trans-perineal guide grid placed the prostate biopsy or ablation procedure.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,764 Total Patients Enrolled
Clear Guide Medical Inc.UNKNOWN
David Woodrum, MD, PhDPrincipal InvestigatorMayo Clinic
4 Previous Clinical Trials
212 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am scheduled for a biopsy or ablation guided by MRI.You are able to handle being put under anesthesia or sedation.I have had cancer other than skin cancer in the last 3 years.
Research Study Groups:
This trial has the following groups:- Group 1: Trans-Perineal Grid for prostate interventions
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this experiment actively seeking out participants?
"According to the information found on clinicaltrials.gov, this research endeavour is not actively recruiting patients right now. The study was first posted on October 4th 2022 and has been modified since then; however, there are three other medical studies that presently require participants' participation."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger